Traci S. Umberger - 17 Jul 2025 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Role
General Counsel and Chief Administrative Officer, Director
Signature
/s/ Traci S. Umberger
Issuer symbol
KMTS
Transactions as of
17 Jul 2025
Net transactions value
$0
Form type
4
Filing time
21 Jul 2025, 17:13:04 UTC
Previous filing
15 Sep 2025
Next filing
31 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Umberger Traci S General Counsel and Chief Administrative Officer, Director C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND /s/ Traci S. Umberger 21 Jul 2025 0001877198

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KMTS Common Shares Award $0 +29,412 +32% $0.000000 120,836 17 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KMTS Options 541,000 17 Jul 2025 Common Shares 541,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 9,804 on July 17, 2026, 9,804 on July 17, 2027 and 9,804 on July 17, 2028.
F2 Includes 324,600 fully vested options and 216,400 options that will vest as follows: 108,200 of such options will vest on March 6, 2026, and the remaining 108,200 will vest monthly over the following year.

Remarks:

General Counsel and Chief Administrative Officer